º»¹® ¹Ù·Î°¡±â Äü¹Ù·Î°¡±â Ä«ÇǶóÀÌÅÍ ¹Ù·Î°¡±â


¼¼¹Ì³ª ¤Ó È­¿ä¾Ï¼¼¹Ì³ª

Home > ±³À° > È­¿ä¾Ï¼¼¹Ì³ª
È­¿ä¾Ï¼¼¹Ì³ª °Ô½ÃÆÇ
ÀϽà Á¦¸ñ ¿¬ÀÚ ÁÂÀå
04¿ù 17ÀÏ Consilience in Clinical and Translational Research for Gastric Cancer ±è¿µ¿ì ¾çÇѱ¤/ÀÌÇõÁØ
04¿ù 10ÀÏ Molecular interactions probed by nuclear magnetic resonance spectroscopy ¼­Á¤¿ë ±è¿µ¼ö
04¿ù 03ÀÏ FIne-tuning of mitosis: BRCA2 reinforces the spindle assembly checkpoint by regulating BUbR1 acetylation ÀÌÇö¼÷ ¹Ú³ëÇö
03¿ù 27ÀÏ Regulation of NADPH oxidase in cell signaling ¹èÀ±¼ö ¼Û¿ë»ó
03¿ù 20ÀÏ ¼¼Æ÷¿Ü±âÁú¼ººÐ¿¡ ÀÇÇÑ Áٱ⼼Æ÷Çൿ Á¶Àý ¹× Á¶Á÷Àç»ý ÇÑÈ£Àç ÀÓ¼®¾Æ
12¿ù 13ÀÏ ¾Ï¼¼Æ÷ÀÇ stiffness¸¦ Á¶ÀýÇÏ´Â »õ·Î¿î Ÿ°Ù ¹ß±¼ ÀÌÃ¢ÈÆ ±¸ÀÚ·Ï
12¿ù 06ÀÏ MET detection in the formaline-fixed and paraffin-embedded tissue and its clinical implications in gastric cancer ÀÌÈñÀº ±è¿ìÈ£
11¿ù 29ÀÏ Metaplasia in the stomach: clue for identifying cancer stem cell and potential tumor biomarkers ÀÌÇõÁØ ¾çÇѱ¤
11¿ù 22ÀÏ Target-based Anticancer Drug Development from Natural Products¡¡ ÀÌ»ó±¹ Àü¾ç¼÷
11¿ù 15ÀÏ Develpment of pan-Her Inhibitor ±è¸Í¼· ÀÓ¼®¾Æ
First page  Prev paging   1 / 2 / 3 / 4 / 5 / 6 / 7 / 8 / 9 / 10   next paging  last page